Genetic Signatures Ltd
ASX:GSS

Watchlist Manager
Genetic Signatures Ltd Logo
Genetic Signatures Ltd
ASX:GSS
Watchlist
Price: 0.36 AUD -10%
Market Cap: 81.8m AUD

Intrinsic Value

The intrinsic value of one GSS stock under the Base Case scenario is 0.71 AUD. Compared to the current market price of 0.36 AUD, Genetic Signatures Ltd is Undervalued by 49%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GSS Intrinsic Value
0.71 AUD
Undervaluation 49%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Genetic Signatures Ltd

What is Valuation History?
Compare GSS to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about GSS?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Genetic Signatures Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Genetic Signatures Ltd

Current Assets 51.6m
Cash & Short-Term Investments 40.8m
Receivables 3.7m
Other Current Assets 7.1m
Non-Current Assets 7.5m
PP&E 7.5m
Efficiency

Free Cash Flow Analysis
Genetic Signatures Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Genetic Signatures Ltd

Revenue
18.4m AUD
Cost of Revenue
-8.7m AUD
Gross Profit
9.7m AUD
Operating Expenses
-25.4m AUD
Operating Income
-15.7m AUD
Other Expenses
-6.9m AUD
Net Income
-22.6m AUD
Fundamental Scores

GSS Profitability Score
Profitability Due Diligence

Genetic Signatures Ltd's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Declining Gross Margin
Declining Net Margin
14/100
Profitability
Score

Genetic Signatures Ltd's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

GSS Solvency Score
Solvency Due Diligence

Genetic Signatures Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Genetic Signatures Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GSS Price Targets Summary
Genetic Signatures Ltd

Wall Street analysts forecast GSS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GSS is 0.77 AUD with a low forecast of 0.76 AUD and a high forecast of 0.79 AUD.

Lowest
Price Target
0.76 AUD
110% Upside
Average
Price Target
0.77 AUD
113% Upside
Highest
Price Target
0.79 AUD
119% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Genetic Signatures Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for GSS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

GSS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one GSS stock?

The intrinsic value of one GSS stock under the Base Case scenario is 0.71 AUD.

Is GSS stock undervalued or overvalued?

Compared to the current market price of 0.36 AUD, Genetic Signatures Ltd is Undervalued by 49%.

Back to Top